Examination of novel non-phosphorus-containing phosphotyrosyl mimetics against protein-tyrosine phosphatase-1B and demonstration of differential affinities toward Grb2 SH2 domains

被引:56
作者
Gao, Y
Wu, L
Luo, JH
Guo, R
Yang, D
Zhang, ZY
Burke, TR
机构
[1] NCI, Med Chem Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA
[3] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
关键词
D O I
10.1016/S0960-894X(00)00124-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibitory potencies were compared of several mono- and dicarboxy-based pTyr mimetics in Grb2 SH2 domain versus PTP1B assays. Although in both systems pTyr residues provide critical binding elements, significant differences in the manner of recognition exist between the two. This is reflected in the current study, where marked variation in relative potencies was observed between the two systems. Of particular note was the poor potency of all monocarboxy-based pTyr mimetics against PTP1B when incorporated into a hexapeptide platform. The recently reported high PTP1B inhibitory potency of similar phenylphosphate mimicking moieties displayed in small molecule, non-peptide structures, raises questions on the limitations of using peptides as platforms for pTyr mimetics in the discovery of small molecule inhibitors. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:923 / 927
页数:5
相关论文
共 28 条
[1]   Ligands for the tyrosine kinase p56lck SH2 domain:: Discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements [J].
Beaulieu, PL ;
Cameron, DR ;
Ferland, JM ;
Gauthier, J ;
Ghiro, E ;
Gillard, J ;
Gorys, V ;
Poirier, M ;
Rancourt, J ;
Wernic, D ;
Llinas-Brunet, M ;
Betageri, R ;
Cardozo, M ;
Hickey, ER ;
Ingraham, R ;
Jakes, S ;
Kabcenell, A ;
Kirrane, T ;
Lukas, S ;
Patel, U ;
Proudfoot, J ;
Sharma, R ;
Tong, L ;
Moss, N .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (10) :1757-1766
[2]   Monocarboxylic-based phosphotyrosyl mimetics in the design of Grb2 SH2 domain inhibitors [J].
Burke, TR ;
Luo, J ;
Yao, ZJ ;
Gao, Y ;
Zhao, H ;
Milne, GWA ;
Guo, RB ;
Voigt, JH ;
King, CR ;
Yang, DJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (03) :347-352
[3]  
Burke TR, 1998, BIOPOLYMERS, V47, P225, DOI 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO
[4]  
2-O
[5]  
Burke TR, 1997, CURR PHARM DESIGN, V3, P291
[6]   4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: A phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides [J].
Burke, TR ;
Ye, B ;
Akamatsu, M ;
Ford, H ;
Yan, XJ ;
Kole, HK ;
Wolf, G ;
Shoelson, SE ;
Roller, PP .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (05) :1021-1027
[7]   Enantioselective synthesis of nonphosphorus-containing phosphotyrosyl mimetics and their use in the preparation of tyrosine phosphatase inhibitory peptides [J].
Burke, TR ;
Yao, ZJ ;
Zhao, H ;
Milne, GWA ;
Wu, L ;
Zhang, ZY ;
Voigt, JH .
TETRAHEDRON, 1998, 54 (34) :9981-9994
[8]   POTENT INHIBITION OF INSULIN-RECEPTOR DEPHOSPHORYLATION BY A HEXAMER PEPTIDE-CONTAINING THE PHOSPHOTYROSYL MIMETIC F(2)PMP [J].
BURKE, TR ;
KOLE, HK ;
ROLLER, PP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 204 (01) :129-134
[9]   PREPARATION OF FLUORO-4-(PHOSPHONOMETHYL)-D,L-PHENYLALANINE AND HYDROXY-4-(PHOSPHONOMETHYL)-D,L-PHENYLALANINE SUITABLY PROTECTED FOR SOLID-PHASE SYNTHESIS OF PEPTIDES CONTAINING HYDROLYTICALLY STABLE ANALOGS OF O-PHOSPHOTYROSINE [J].
BURKE, TR ;
SMYTH, MS ;
NOMIZU, M ;
OTAKA, A ;
ROLLER, PP .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (06) :1336-1340
[10]  
BURKE TR, 2000, BIOMEDICAL CHEM APPL, P189